Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 5 November 2019, 23:05 HKT/SGT

Source: Jacobson Pharma Corporation Limited
Jacobson Pharma Adds Excilor to Its Portfolio to Develop China Market with Vemedia (The Netherlands)

HONG KONG, Nov 5, 2019 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and proprietary medicines, announced today that its wholly-owned subsidiary Jacobson Medical (Hong Kong) Limited ("Jacobson") has signed an exclusive distribution agreement (the "Agreement") with Vemedia Shine Limited ("Vemedia") (a wholly-owned subsidiary of Versailles B.V., a company incorporated in the Netherlands) for the marketing and distribution of "Excilor" range of products in the market of Mainland China.

Photo for product(s) of Excilor being currently sold in Hong Kong. Excilor is a leading over-the-counter brand in Hong Kong for nail and foot care.

Jacobson will be the exclusive distributor for Vemedia for the marketing, sales and distribution of Vemedia's highly recognised medicated nail and foot care brand, namely "Excilor", in the China market for a term of ten years.

Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma remarked, "The strategic collaboration represents a sound leverage of strengths and resources between Jacobson and Vemedia. By riding on its established market network, Jacobson Pharma aims to build a strong position for the Excilor brand whilst tapping the fast-growing nail and foot care market in China. It is one of our strategic goals to maximize the value and market potential of the Excilor brand and create synergies with Vemedia via a sustainable collaboration."

The appointment of Jacobson as the exclusive distributor of Excilor in the Mainland China will enhance the product portfolio of Jacobson Pharma and further strengthen its market position in capitalizing on the rising consumer demand for branded healthcare products in the burgeoning market of China.

Jacobson Pharma has been forging strategic collaborations with various business partners. A case in point is the recently-formed joint venture alliance with Weisen-U and Flucur Nebuliser. The Group currently possesses a portfolio of proprietary healthcare brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil, and Col-gan Tablet.

About Jacobson Pharma Corporation Limited (Stock Code: 2633)
Jacobson Pharma is a leading generic drug company in Hong Kong. The Group's proprietary medicines, notably being Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognised by the market. The Group aims to enrich its portfolio through addition of high value-added products covering sterile injections, oncology products as well as orphan drugs and biosimilars. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website:

About Vemedia Shine Limited
Vemedia is a fast growing reputable consumer healthcare company headquartered in Diemen, the Netherlands, marketing a portfolio of leading self-medicated brands in certain European countries. Excilor, a well-recognized brand under Vemedia, primes itself as the specialist in medical foot care and enjoys a preeminent position in the over-the-counter (OTC) market for the treatment of fungal nail infection.

Nov 5, 2019 23:05 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, HealthCare
From the Asia Corporate News Network

Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Jacobson Pharma Corporation Limited
Feb 5, 2020 18:40 HKT/SGT
Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau
Nov 26, 2019 17:24 HKT/SGT
Jacobson Pharma Announces FY2020 Interim Results
Nov 12, 2019 21:05 HKT/SGT
Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region
Oct 31, 2019 20:25 HKT/SGT
Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U
Aug 15, 2019 19:00 HKT/SGT
HKTDC Food Expo opens featuring new Coffee Avenue zone
June 25, 2019 20:00 HKT/SGT
Jacobson Pharma Announces FY2019 Annual Results
May 8, 2019 20:15 HKT/SGT
Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations
May 2, 2019 22:39 HKT/SGT
Jacobson Pharma Issues Positive Profit Alert
Nov 21, 2018 22:43 HKT/SGT
Jacobson Pharma Announces FY2019 Interim Results
June 25, 2018 22:00 HKT/SGT
Jacobson Pharma Announces 2018 Annual Results
More news >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: